Ignite Creation Date:
2024-05-06 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06190561
Status:
COMPLETED
Last Update Posted:
2024-06-13
First Post:
2023-12-19
Brief Title:
A Study to Learn How Different Products of the Study Medicine Called PF-07940367 Are Taken up Into the Blood in Healthy Adults
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A PHASE 1 OPEN-LABEL RANDOMIZED SINGLE-DOSE PARALLEL DESIGN STUDY TO EVALUATE PHARMACOKINETIC COMPARABILITY OF TWO PF-07940367 FILM-COATED TABLET FORMULATIONS ADMINISTERED AS 150 MG UNDER FASTED CONDITIONS IN HEALTHY PARTICIPANTS
Status:
COMPLETED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare two finished products of PF-07940367 in terms of the uptake into the blood stream
This study is seeking participants who are
- Healthy male or female participants aged 18 years or older
All participants in this study will receive PF-07940367 once by mouth The participants may receive different tablets by mouth for PF-07940367
The study will compare experiences of people receiving two different products of PF-07940367 This will help understand how much PF-07940367 is taken up into the blood for each product given
Participants will take part in the study for about 112 days During this time participants will have to stay onsite for 5 days There will be up to 2 additional onsite study visits and 3 remote telephone call study visits
This study is seeking participants who are
- Healthy male or female participants aged 18 years or older
All participants in this study will receive PF-07940367 once by mouth The participants may receive different tablets by mouth for PF-07940367
The study will compare experiences of people receiving two different products of PF-07940367 This will help understand how much PF-07940367 is taken up into the blood for each product given
Participants will take part in the study for about 112 days During this time participants will have to stay onsite for 5 days There will be up to 2 additional onsite study visits and 3 remote telephone call study visits
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| GBT BEFE adult formulation | OTHER | Alias Study Number | None |